Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus Directory of Open Access Journals kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Correlation between Blood Type 0 and Risk of Chronic Subdural Hematoma Recurrence: A Single Center Retrospective Cohort Study

Title: Correlation between Blood Type 0 and Risk of Chronic Subdural Hematoma Recurrence: A Single Center Retrospective Cohort Study
Authors: Motaz Hamed; Tim Lampmann; Abdallah Salemdawod; Harun Asoglu; Naomi Houedjissin; Marcus Thudium; Lakghomi Asadeh; Frederic Carsten Schmeel; Fabiane Schuch; Hartmut Vatter; Mohammed Banat
Source: Brain Sciences, Vol 13, Iss 4, p 567 (2023)
Publisher Information: MDPI AG, 2023.
Publication Year: 2023
Collection: LCC:Neurosciences. Biological psychiatry. Neuropsychiatry
Subject Terms: chronic subdural hematoma; ABO blood type; minor head trauma; Neurosciences. Biological psychiatry. Neuropsychiatry; RC321-571
Description: Chronic subdural hematoma (cSDH) is a common disease in the neurological and neurosurgical world. The recommended treatment for cSDH patients with moderate or severe neurological symptoms is surgical evacuation, but cSDH frequently recurs. The patient’s ABO blood type may influence the outcome. This study aims to evaluate the correlation between cSDH recurrence and blood type O. We performed a retrospective analysis of the data of patients with cSDH who were surgically treated. Recurrence was defined as the need for re-operation within the first 12 weeks after the initial surgery. We analyzed standard demographic data, duration and type of surgery, ABO blood types, and the re-operation rate. Univariate and multivariate analyses were conducted. A total of 229 patients were included. The recurrence of hematoma was identified in 20.5% of patients. Blood type O was found to be significantly associated with cSDH recurrence leading to re-operation within 12 weeks (p = 0.02, OR 1.9, 95% CI 1.1–3.5). Thrombocyte aggregation inhibition and oral anticoagulants were not predictors of cSDH recurrence. Patients with blood type O in our cohort were identified to be at higher risk of cSDH recurrence and may, therefore, be a more vulnerable patient group. This finding needs further evaluation in larger cohorts.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2076-3425
Relation: https://www.mdpi.com/2076-3425/13/4/567; https://doaj.org/toc/2076-3425
DOI: 10.3390/brainsci13040567
Access URL: https://doaj.org/article/d65ddc3bf018400a9f1edf4a1ffefaf9
Accession Number: edsdoj.65ddc3bf018400a9f1edf4a1ffefaf9
Database: Directory of Open Access Journals